Helicobacter pylori employs a general protein glycosylation system for the modification of outer membrane adhesins

Area of Science:

• Microbiology
• Molecular Biology
• Glycobiology

Background:

• Helicobacter pylori infection is a major cause of gastric diseases, including cancer.
• H. pylori utilizes outer membrane adhesins for gastric mucosa colonization, but their redundancy complicates therapeutic targeting.
• Individual adhesin targeting yields suboptimal outcomes due to functional redundancy.

Purpose of the Study:

• To investigate the glycosylation of H. pylori adhesins AlpA/B and BabA/B.
• To elucidate the relationship between adhesin glycosylation and lipopolysaccharide (LPS) biosynthesis pathways.
• To identify potential drug targets for preventing H. pylori adhesion and infection.

Main Methods:

• Analysis of adhesin molecular weight shifts during cellular localization.
• Investigating the impact of disrupted LPS biosynthesis enzymes (WecA, Wzk, WaaL) on adhesin glycosylation.
• Assessing the effects of altered glycosylation on adhesin stability, protease resistance, and binding ability.
• Evaluating bacterial adhesion in an in vitro cell-line model using LPS biosynthesis mutants.

Main Results:

• Key H. pylori adhesins (AlpA/B, BabA/B) exhibit a two-step molecular weight upshift, indicating glycan modification.
• This glycosylation pattern is absent when LPS biosynthesis enzymes are disrupted, suggesting shared pathways.
• Loss of adhesin glycosylation reduces adhesin stability and binding ability.
• Mutations in LPS biosynthesis significantly decrease H. pylori adhesion in vitro.

Conclusions:

• H. pylori employs a general protein glycosylation system linked to LPS biosynthesis for adhesin modification.
• This shared glycosylation system is crucial for adhesin function and bacterial adhesion.
• Enzymes involved in adhesin glycosylation, rather than adhesins themselves, represent promising therapeutic targets for H. pylori infection.